PL1704154T3 - Nowe indeno[2,1a]indeny i izoindolo[2,1-a]indole - Google Patents

Nowe indeno[2,1a]indeny i izoindolo[2,1-a]indole

Info

Publication number: PL1704154T3
Authority: PL; Poland
Prior art keywords: sub; disorders; indenes; isoindol; indoles
Prior art date: 2004-01-02

Application number

PL04806777T

Other languages

English (en)

Inventor

Venkateswarlu Jasti

Venkata Satya Nirogi Ramakrishna

Rama Sastri Kambhampati

Vikas Shreekrishna Shirsath

Nagaraj Kandikere Vishwottam

Original Assignee

Suven Life Sciences Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-01-02

Filing date

2004-12-30

Publication date

2009-10-30

2004-12-30 Application filed by Suven Life Sciences Ltd filed Critical Suven Life Sciences Ltd

2009-10-30 Publication of PL1704154T3 publication Critical patent/PL1704154T3/pl

Links

VHMICKWLTGFITH-UHFFFAOYSA-N 2H-isoindole Chemical compound C1=CC=CC2=CNC=C21 VHMICKWLTGFITH-UHFFFAOYSA-N 0.000 title 1
QKDLQFSLLCQTOH-UHFFFAOYSA-N Trichodonin Natural products C1C(O)C2C3(COC(=O)C)C(C=O)C(C)(C)CCC3OC(=O)C22C(=O)C(=C)C1C2 QKDLQFSLLCQTOH-UHFFFAOYSA-N 0.000 title 1
150000002469 indenes Chemical class 0.000 title 1
150000002475 indoles Chemical class 0.000 title 1
150000001875 compounds Chemical class 0.000 abstract 3
238000000034 method Methods 0.000 abstract 2
JJUQRPHMJPHFBH-UHFFFAOYSA-N 6h-isoindolo[2,1-a]indole Chemical class C1=CC=C2N3CC4=CC=CC=C4C3=CC2=C1 JJUQRPHMJPHFBH-UHFFFAOYSA-N 0.000 abstract 1
208000024172 Cardiovascular disease Diseases 0.000 abstract 1
208000030814 Eating disease Diseases 0.000 abstract 1
208000019454 Feeding and Eating disease Diseases 0.000 abstract 1
201000011529 cardiovascular cancer Diseases 0.000 abstract 1
208000015114 central nervous system disease Diseases 0.000 abstract 1
OZEPXROCWSMGGM-UHFFFAOYSA-N dibenzopentalene Chemical compound C1=CC=C2C=C3C4=CC=CC=C4C=C3C2=C1 OZEPXROCWSMGGM-UHFFFAOYSA-N 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
235000014632 disordered eating Nutrition 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
208000014951 hematologic disease Diseases 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
208000023504 respiratory system disease Diseases 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
208000014001 urinary system disease Diseases 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Addiction (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Hematology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Psychology (AREA)
Diabetes (AREA)
Reproductive Health (AREA)
Pulmonology (AREA)
Nutrition Science (AREA)
Endocrinology (AREA)
Obesity (AREA)
Gastroenterology & Hepatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

PL04806777T 2004-01-02 2004-12-30 Nowe indeno[2,1a]indeny i izoindolo[2,1-a]indole PL1704154T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
IN5CH2004		2004-01-02
PCT/IN2004/000430 WO2005066184A1 (en)	2004-01-02	2004-12-30	Novel indeno[2,1a]indenes and isoindol[2,1-a]indoles
EP04806777A EP1704154B1 (en)	2004-01-02	2004-12-30	Novel indeno [2,1a]indenes and isoindol [2,1-a]indoles

Publications (1)

Publication Number	Publication Date
PL1704154T3 true PL1704154T3 (pl)	2009-10-30

Family

ID=34746651

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL04806777T PL1704154T3 (pl)	2004-01-02	2004-12-30	Nowe indeno[2,1a]indeny i izoindolo[2,1-a]indole

Country Status (24)

Country	Link
US (1)	US7388024B2 (pl)
EP (1)	EP1704154B1 (pl)
JP (1)	JP4886522B2 (pl)
KR (1)	KR101049868B1 (pl)
CN (1)	CN1918173B (pl)
AT (1)	ATE430752T1 (pl)
AU (1)	AU2004312229B2 (pl)
BR (1)	BRPI0417895B8 (pl)
CA (1)	CA2552106C (pl)
CY (1)	CY1109278T1 (pl)
DE (1)	DE602004021031D1 (pl)
DK (1)	DK1704154T3 (pl)
EA (1)	EA010406B1 (pl)
ES (1)	ES2326658T3 (pl)
HR (1)	HRP20090419T1 (pl)
MX (1)	MXPA06007415A (pl)
NO (1)	NO335838B1 (pl)
NZ (1)	NZ548743A (pl)
PL (1)	PL1704154T3 (pl)
PT (1)	PT1704154E (pl)
RS (1)	RS50824B (pl)
SI (1)	SI1704154T1 (pl)
WO (1)	WO2005066184A1 (pl)
ZA (1)	ZA200604748B (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN102482292B (zh) *	2009-04-23	2017-07-18	Abbvie 公司	5‑ht受体的调节剂和其使用方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5994352A (en) *	1998-11-13	1999-11-30	Pfizer Inc.	5-arylindole derivatives
WO2002051837A2 (en) *	2000-12-22	2002-07-04	Wyeth	Heterocyclindazole and azaindazole compounds as 5-hydroxytryptamine-6 ligands
ATE340795T1 (de) *	2001-01-30	2006-10-15	Lilly Co Eli	Benzolsulfonsäureester-indol-5-yl als 5-ht6 rezeptor-antagonisten
DE60218194T2 (de)	2001-10-23	2007-10-31	Biovitrum Ab	Verwendung von indol- und indolin-derivaten bei der behandlung von adipositas oder zur reduzierung der nahrungsaufnahme
ES2187300B1 (es) *	2001-11-14	2004-06-16	Laboratorios Del Dr. Esteve, S.A.	Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos.
ATE335477T1 (de) *	2001-12-20	2006-09-15	Wyeth Corp	Indolylalkylamin-derivate als 5-hydroxytryptamin- 6 liganden
WO2003065046A2 (en)	2002-02-01	2003-08-07	Bayer Healthcare Ag	Diagnostics and therapeutics for diseases associated with a new human 5-ht6 receptor
AU2003244452A1 (en)	2002-02-05	2003-09-02	Glaxo Group Limited	Method of promoting neuronal growth
DK1523486T3 (da) *	2002-06-21	2008-03-03	Suven Life Sciences Ltd	Tetracykliske arylsulfonylindoler med serotoninreceptor-affinitet
DE60329607D1 (de) *	2002-06-21	2009-11-19	Suven Life Sciences Ltd	Sich als therapeutische mittel eignende arylalkylindole mit affinität für den serotoninrezeptor, verfahren zu deren herstellung und pharmazeutische zusammensetzungen, die diese enthalten
ES2276109T3 (es) *	2002-06-21	2007-06-16	Suven Life Sciences Limited	Nuevos indoles arilcarbonilicos tetraciclicos que tienen afinidad por el receptor de serotonina, utiles como agentes terapeuticos, proceso para su preparacion y mezclas farmaceuticas que los contienen.
MXPA05005700A (es)	2002-11-28	2005-08-16	Suven Life Sciences Ltd	N-arilsulfonil-3-aminoalcoxiindoles.
AU2003292508A1 (en)	2002-11-28	2004-06-18	Suven Life Sciences Limited	N-arylalkyl-3-aminoalkoxyindoles and their use as 5-ht ligands
JP4559230B2 (ja)	2002-11-28	2010-10-06	スベンライフサイエンシズリミティド	セロトニン受容体に対する親和性を有する新規ｎ−アリールスルホニル−３−置換されたインドール、その調製方法、それを含有する医薬組成物
EA009367B1 (ru)	2002-12-18	2007-12-28	Сувен Лайф Сайенсиз Лимитед	ПРОИЗВОДНЫЕ 5-ТИА-5-ДИОКСО-4b-АЗАИНДЕНО[2,1-a]ИНДЕНА, ОБЛАДАЮЩИЕ АФФИННОСТЬЮ К РЕЦЕПТОРУ СЕРОТОНИНА

2004
- 2004-12-30 AU AU2004312229A patent/AU2004312229B2/en not_active Ceased
- 2004-12-30 CA CA2552106A patent/CA2552106C/en not_active Expired - Fee Related
- 2004-12-30 HR HR20090419T patent/HRP20090419T1/hr unknown
- 2004-12-30 EA EA200601270A patent/EA010406B1/ru not_active IP Right Cessation
- 2004-12-30 JP JP2006546485A patent/JP4886522B2/ja not_active Expired - Fee Related
- 2004-12-30 PT PT04806777T patent/PT1704154E/pt unknown
- 2004-12-30 PL PL04806777T patent/PL1704154T3/pl unknown
- 2004-12-30 ES ES04806777T patent/ES2326658T3/es not_active Expired - Lifetime
- 2004-12-30 SI SI200431175T patent/SI1704154T1/sl unknown
- 2004-12-30 MX MXPA06007415A patent/MXPA06007415A/es active IP Right Grant
- 2004-12-30 WO PCT/IN2004/000430 patent/WO2005066184A1/en not_active Ceased
- 2004-12-30 BR BRPI0417895A patent/BRPI0417895B8/pt not_active IP Right Cessation
- 2004-12-30 CN CN2004800417654A patent/CN1918173B/zh not_active Expired - Fee Related
- 2004-12-30 RS RSP-2009/0329A patent/RS50824B/sr unknown
- 2004-12-30 DK DK04806777T patent/DK1704154T3/da active
- 2004-12-30 EP EP04806777A patent/EP1704154B1/en not_active Expired - Lifetime
- 2004-12-30 KR KR1020067012980A patent/KR101049868B1/ko not_active Expired - Fee Related
- 2004-12-30 DE DE602004021031T patent/DE602004021031D1/de not_active Expired - Lifetime
- 2004-12-30 AT AT04806777T patent/ATE430752T1/de active
- 2004-12-30 NZ NZ548743A patent/NZ548743A/xx not_active IP Right Cessation
2006
- 2006-06-09 ZA ZA200604748A patent/ZA200604748B/xx unknown
- 2006-06-15 NO NO20062805A patent/NO335838B1/no not_active IP Right Cessation
- 2006-06-29 US US11/478,968 patent/US7388024B2/en not_active Expired - Lifetime
2009
- 2009-08-03 CY CY20091100812T patent/CY1109278T1/el unknown

Also Published As

Publication number	Publication date
SI1704154T1 (sl)	2009-12-31
EA200601270A1 (ru)	2006-12-29
US7388024B2 (en)	2008-06-17
EP1704154B1 (en)	2009-05-06
CN1918173B (zh)	2011-09-14
NO20062805L (no)	2006-09-25
BRPI0417895B1 (pt)	2020-03-03
HRP20090419T1 (hr)	2009-09-30
JP2007517791A (ja)	2007-07-05
AU2004312229B2 (en)	2010-05-20
CN1918173A (zh)	2007-02-21
WO2005066184A1 (en)	2005-07-21
JP4886522B2 (ja)	2012-02-29
PT1704154E (pt)	2009-08-05
DE602004021031D1 (de)	2009-06-18
AU2004312229A1 (en)	2005-07-21
NO335838B1 (no)	2015-03-02
HK1097548A1 (en)	2007-06-29
NZ548743A (en)	2009-07-31
EP1704154A1 (en)	2006-09-27
EA010406B1 (ru)	2008-08-29
CA2552106A1 (en)	2005-07-21
MXPA06007415A (es)	2007-01-26
BRPI0417895B8 (pt)	2021-05-25
KR101049868B1 (ko)	2011-07-19
BRPI0417895A (pt)	2008-03-04
ATE430752T1 (de)	2009-05-15
CA2552106C (en)	2011-10-11
ZA200604748B (en)	2007-11-28
US20070054946A1 (en)	2007-03-08
DK1704154T3 (da)	2009-08-31
KR20070008541A (ko)	2007-01-17
ES2326658T3 (es)	2009-10-16
CY1109278T1 (el)	2014-07-02
RS50824B (sr)	2010-08-31

Publication	Publication Date	Title
DE60219954D1 (de)	2007-06-14	Neue Indol-2-on Derivate
PL1697370T3 (pl)	2007-09-28	Azabicykliczne heterocykle jako modulatory receptora kanabinoidowego
MY144483A (en)	2011-09-30	1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases
EP1619192A3 (en)	2006-03-22	Aryl fused azapolycyclic compounds
EA200600811A1 (ru)	2006-10-27	НОВЫЕ ПРОИЗВОДНЫЕ ТЕТРАГИДРОСПИРО {ПИПЕРИДИН-2,7'-ПИРРОЛО [3,2-b]ПИРИДИНА} И НОВЫЕ ПРОИЗВОДНЫЕ ИНДОЛА, ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ РАССТРОЙСТВ, СВЯЗАННЫХ С 5-HT-РЕЦЕПТОРОМ
DE60231341D1 (de)	2009-04-09	Fluor- und sulfonylaminohaltige, 3,6-disubstituierptorantagonisten
IL148103A0 (en)	2002-09-12	Novel dicarboxylic acid derivatives with pharmaceutical properties
TW200635903A (en)	2006-10-16	Therapeutic agents
WO2005037798A3 (en)	2005-06-16	Amide or thiomide derivatives and their use in the treatment of pain
EA200500173A1 (ru)	2005-08-25	Производные 3,6-дизамещенного азабицикло[3.1.0]гексана в качестве антагонистов мускариновых рецепторов
AU2002359162A1 (en)	2003-07-15	Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer's disease and conditions associated with glycogen synthase kinase-3
TW200509933A (en)	2005-03-16	Therapeutic agents
TW200716547A (en)	2007-05-01	Piperidin-4-yl-amide derivatives
BG104983A (en)	2001-09-28	Aryl fused azapolycyclic compounds
AU2002347553A1 (en)	2004-07-14	Flavaxate derivatives as muscarinic receptor antagonists
AU2003214535A8 (en)	2004-11-01	Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
IL163608A (en)	2013-12-31	Sulfonanilides are conserved in their amino / amino acids and derivatives, their process, their pharmaceutical preparations, and their conjugated antibodies and their use in the preparation of drugs for the treatment of culture disorders
YU19302A (sh)	2004-11-25	4-benzilaminohinolin konjugovan žučnom kiselinom i njegovi heteroanalozi, postupak za njihovu proizvodnju, lekovi koji sadrže ta jedinjenja i njihova primena
ATE393624T1 (de)	2008-05-15	Verwendung von sesquiterpene enthaltenden zusammenstellungen zur behandlung von krebs
ZA200604748B (en)	2007-11-28	Novel indeno[2,1A]indenes and isoindol[2,1-A]indoles
PT1651592E (pt)	2009-07-23	Novas dibenzo[b,f]oxepino-10-carboxamidas e suas utilizações farmacêuticas
SG146685A1 (en)	2008-10-30	Dihydroporphine derivatives, processes for their preparation, and pharmaceutical compositions containing them
MX2008001607A (es)	2008-04-14	Piperazinas biciclicas como antagonistas del receptor de glutamato metabotropico.
MXPA05003633A (es)	2005-12-14	2"-oxo-voruscharina y derivados de la misma.
GB9926301D0 (en)	2000-01-12	Novel compounds